Related references
Note: Only part of the references are listed.Gene therapy rescues cone function in congenital achromatopsia
Andras M. Komaromy et al.
HUMAN MOLECULAR GENETICS (2010)
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Albert M. Maguire et al.
LANCET (2009)
AAV-mediated Tyrosinase Gene Transfer Restores Melanogenesis and Retinal Function in a Model of Oculo-cutaneous Albinism Type I (OCA1)
Annagiusi Gargiulo et al.
MOLECULAR THERAPY (2009)
Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis
Artur V. Cideciyan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction
Sami Ellouze et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Sucess in sight: The eyes have it! Ocular gene therapy trials for LCA look promising
J. W. Bainbridge et al.
GENE THERAPY (2008)
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
William W. Hauswirth et al.
HUMAN GENE THERAPY (2008)
Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration
Pamela S. Lagali et al.
NATURE NEUROSCIENCE (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Bioluminescent imaging of Ca2+ activity reveals spatiotemporal dynamics in glial networks of dark-adapted mouse retina
Cendra Agulhon et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium
G. Le Meur et al.
GENE THERAPY (2007)
Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in leber congenital amaurosis
Samuel G. Jacobson et al.
HUMAN GENE THERAPY (2006)
Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration
AD Bi et al.
NEURON (2006)
Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis
JJ Pang et al.
MOLECULAR THERAPY (2006)
Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness
GM Acland et al.
MOLECULAR THERAPY (2005)
Excessive activation of cyclic nucleotide-gated channels contributes to neuronal degeneration of photoreceptors
G Vallazza-Deschamps et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
In utero gene therapy rescues vision in a murine model of congenital blindness
NS Dejneka et al.
MOLECULAR THERAPY (2004)
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model
A Auricchio et al.
HUMAN MOLECULAR GENETICS (2001)
Gene therapy restores vision in a canine model of childhood blindness
GM Acland et al.
NATURE GENETICS (2001)
Cell differentiation, synaptogenesis, and influence of the retinal pigment epithelium in a rat neonatal organotypic retina culture
G Pinzon-Duarte et al.
VISION RESEARCH (2000)
Share Paper
